Stimulant abuse and sudden cardiac death

TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law

Volumn , Issue , 2009, Pages 315-325

  Karch, Steven B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955816041     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-85475-5_26     Document Type: Chapter

References (51)

1. Ma YL, Peters NS, Henry JA. Alpha 1-acid glycoprotein reverses cocaine-induced sodium channel blockade in cardiac myocytes. Toxicology 2006;220:46-50.
2. Karle CA, Kiehn J. An ion channel 'addicted' to ether, alcohol and cocaine: the HERG potassium channel. Cardiovasc Res 2002;53:6-8.
3. Karch SB, Green GS, Young S. Myocardial hypertrophy and coronary artery disease in male cocaine users. J Forensic Sci 1995;40:591-5.
4. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci 1999;44:359-68.
5. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 2006;367:356-67.
6. Shah M, Akar FG, Tomaselli GF. Molecular basis of arrhythmias. Circulation 2005;112:2517-29.
7. de Simone G. Concentric or eccentric hypertrophy: how clinically relevant is the difference? Hypertension 2004;43:714-5.
8. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB. Contemporary definitions and classification of the cardiomyopathies: an American heart association scientific statement from the council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-16.
9. Abbate A, Scarpa S, Santini D, Palleiro J, Vasaturo F, Miller J, Morales C, Vetrovec GW, Baldi A. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. Int J Cardiol 2006;111:371-6.
10. Lafontant PJ, Field LJ. The cardiomyocyte cell cycle. Novartis Found Symp 2006;274:196-207; discussion 208-13, 272-6.
11. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999;79:215-62.
12. Henning RJ, Cuevas J. Cocaine activates calcium/calmodulin kinase II and causes cardiomyocyte hypertrophy. J Cardiovasc Pharmacol 2006;48:802-13.
13. Henning RJ, Silva J, Reddy V, Kamat S, Morgan MB, Li YX, Chiou S. Cocaine increases beta-myosin heavy-chain protein expression in cardiac myocytes. J Cardiovasc Pharmacol Ther 2000;5:313-22.
14. Wijetunga M, Seto T, Lindsay J, Schatz I. Crystal methamphetamine- associated cardiomyopathy: tip of the iceberg? J Toxicol Clin Toxicol 2003;41:981-6.
15. Arora S, Alfayoumi F, Srinivasan V. Transient left ventricular apical ballooning after cocaine use: is catecholamine cardiotoxicity the pathologic link? Mayo Clin Proc 2006;81:829-32.
16. Furukawa T, Kurokawa J. Potassium channel remodeling in cardiac hypertrophy. J Mol Cell Cardiol 2006;41:753-61.
17. Guo J, Gang H, Zhang S. Molecular determinants of cocaine block of human ether-a-gogo-related gene potassium channels. J Pharmacol Exp Ther 2006;317:865-74.
18. Wu Y, Temple J, Zhang R, Dzhura I, Zhang W, Trimble R, Roden DM, Passier R, Olson EN, Colbran RJ, Anderson ME. Calmodulin kinase IIand arrhythmias ina mouse model of cardiac hypertrophy. Circulation 2002;106:1288-93.
19. Kirchhof P, Fabritz L, Kilic A, Begrow F, Breithardt G, Kuhn M. Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice. J Mol Cell Cardiol 2004;36:691-700.
20. Ouchi Y, Kubota Y, Ito C. Serial analysis of gene expression in methamphetamine- and phencyclidine-treated rodent cerebral cortices: are there common mechanisms? Ann N Y Acad Sci 2004;1025:57-61.
21. McKinsey TA. Derepression of pathological cardiac genes by members of the CaM kinase superfamily. Cardiovasc Res 2007;73:667-77.
22. Kannel WB, Abbott RD. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham Study. Am Heart J 1986;111:391-7.
23. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998;32:1454-9.
24. Karch SB, Stephens BG. Drug abusers who die during arrest or in custody. J R Soc Med 1999;92:110-3.
25. Patel MM, Belson MG, Wright D, Lu H, Heninger M, Miller MA. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study. Resuscitation 2005;66:197-202.
26. Yarom R, Levy E, Horowitz M. Myocardial pathology in rats exposed to prolonged environmental heat. Cardiovasc Res 1990;24:982-6.
27. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986;74:964-72.
28. Mosseri M, Schaper J, Admon D, Hasin Y, Gotsman MS, Sapoznikov D, Pickering JG, Yarom R. Coronary capillaries in patients with congestive cardiomyopathy or angina pectoris with patent main coronary arteries. Ultrastructural morphometry of endomyocardial biopsy samples. Circulation 1991;84:203-10.
29. Bishop AH, Samady H. Fractional flow reserve: critical review of an important physiologic adjunct to angiography. Am Heart J 2004;147:792-802.
30. Karch SB, Wetli CV. Agitated delirium versus positional asphyxia. Ann Emerg Med 1995;26:760-1.
31. Anderson KP. Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances. Ann Noninvasive Electrocardiol 2003;8:75-89.
32. Anderson ME. QT interval prolongation and arrhythmia: an unbreakable connection? J Intern Med 2006;259:81-90.
33. Antzelevitch C. Cardiac repolarization. The long and short of it. Europace 2005;7 Suppl 2:3-9.
34. Kang J, Reynolds WP, Chen XL, Ji J, Wang H, Rampe DE. Mechanisms underlying the QT interval-prolonging effects of sevoflurane and its interactions with other QT-prolonging drugs. Anesthesiology 2006;104:1015-22.
35. Schillaci G, Pirro M, Ronti T, Gemelli F, Pucci G, Innocente S, Porcellati C, Mannarino E. Prognostic impact of prolonged ventricular repolarization in hypertension. Arch Intern Med 2006;166:909-13.
36. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marban E, Tomaselli GF, Lima JA, Wu KC. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007;115:2006-14.
37. Burns J, Sivananthan MU, Ball SG, Mackintosh AF, Mary DA, Greenwood JP. Relationship between central sympathetic drive and magnetic resonance imagingdetermined left ventricular mass in essential hypertension. Circulation 2007;115:1999-2005.
38. Witchel HJ. The hERG potassium channel as a therapeutic target. Expert Opin Ther Targets 2007;11:321-36.
39. Gunne LM, Jonsson J. Effects of cocaine administration on brain, adrenal and urinary adrenaline and noradrenaline in rats. Psychopharmacologia 1964;6:125-9.
40. Chiueh CC, Kopin IJ. Radioenzymatic paper-chromatographic assay for dopamine and norepinephrine in cerebroventricular cisternal perfusate of cat following administration of cocaine or d-amphetamine. J Neurochem 1978;31:561-4.
41. Dixon WR, Chang AP, Machado J, Lau B, Thompson A, Gallagher S, Sanders W. Effect of intravenous infusion and oral self-administration of cocaine on plasma and adrenal catecholamine levels and cardiovascular parameters in the conscious rat. NIDA Res Monogr 1989;95:335-6.
42. Kiritsy-Roy JA, Halter JB, Gordon SM, Smith MJ, Terry LC. Role of the central nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats. J Pharmacol Exp Ther 1990;255:154-60.
43. Mahlakaarto J, Ruskoaho H, Huttunen P, MacDonald E, Pasanen M. Norcocaine is a potent modulator of haemodynamic responses, plasma catecholamines and cardiac hormone release in conscious rats. Toxicology 1998;128:101-11.
44. Hong K, Kusano KF, Morita H, Fujimoto Y, Nakamura K, Yamanari H, Ohe T. Involvement of Ca (2+) in antiarrhythmic effect of ischemic preconditioning in isolated rat heart. Jpn J Physiol 2000;50:207-13.
45. Pak HN, Kim YH, Lim HE, Chou CC, Miyauchi Y, Fang YH, Sun K, Hwang C, Chen PS. Role of the posterior papillary muscle and purkinje potentials in the mechanism of ventricular fibrillation in open chest dogs and Swine: effects of catheter ablation. J Cardiovasc Electrophysiol 2006;17:777-83.
46. Han J, Garciadejalon P, Moe GK. Adrenergic effects on ventricular vulnerability. Circ Res 1964;14:516-24.
47. Stratton SJ, Rogers C, Brickett K, Gruzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med 2001;19:187-91.
48. ® electronic control device. Europace 2008;8 submitted.
49. Ruttenber AJ, Lawler-Heavner J, Yin M, Wetli CV, Hearn WL, Mash DC. Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity. J Forensic Sci 1997;42:25-31.
50. Staley JK, Talbot JZ, Ciliax BJ, Miller GW, Levey AI, Kung MP, Kung HF, Mash DC. Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims. Brain Res 1997;747:219-29.
51. Qin Y, Ouyang Q, Pablo J, Mash DC. Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport 2005;16:1489-93.